Clinical Trial Update: Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Bevacizumab-IRDye800CW for detecting central lymph node metastases in thyroid cancer during surgery has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Bevacizumab-IRDye800CW

Snippet

Sponsor: University Medical Center Groningen | Conditions: Thyroid Carcinoma, Surgery | Phase 1 | Status: COMPLETED